Bioventus Inc - Class A logo

BVS

Bioventus Inc - Class A

$8.48

Earnings Summary

Revenue
$117.29Mn
Net Profits
$-11.28Mn
Net Profit Margins
-9.61%

Highlights

Revenue:

Bioventus Inc - Class A’s revenue jumped 43.42% since last year same period to $117.29Mn in the Q1 2022. On a quarterly growth basis, Bioventus Inc - Class A has generated -10.06% fall in its revenue since last 3-months.

Net Profits:

Bioventus Inc - Class A’s net profit fell -145.22% since last year same period to $-11.28Mn in the Q1 2022. On a quarterly growth basis, Bioventus Inc - Class A has generated -2998.08% fall in its net profits since last 3-months.

Net Profit Margins:

Bioventus Inc - Class A’s net profit margin fell -131.53% since last year same period to -9.61% in the Q1 2022. On a quarterly growth basis, Bioventus Inc - Class A has generated -3344.73% fall in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Bioventus Inc - Class A post its latest quarter earnings

EPS Estimate Current Quarter
0.05
EPS Estimate Current Year
0.05

Highlights

EPS Estimate Current Quarter:

Bioventus Inc - Class A’s earning per share (EPS) estimates for the current quarter stand at 0.05 - a -72.22% fall from last quarter’s estimates.

EPS Estimate Current Year:

Bioventus Inc - Class A’s earning per share (EPS) estimates for the current year stand at 0.05.

Key Ratios

Key ratios of the Bioventus Inc - Class A post its Q1 2022 earnings

Earning Per Share (EPS)
0.04
Return on Assets (ROA)
-0.01
Return on Equity (ROE)
-0.07
Dividend Per Share (DPS)
0

Highlights

Earning Per Share (EPS):

Bioventus Inc - Class A’s earning per share (EPS) fell -73.33% since last year same period to 0.04 in the Q1 2022. This indicates that the Bioventus Inc - Class A has generated -73.33% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Bioventus Inc - Class A’s return on assets (ROA) stands at -0.01.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Bioventus Inc - Class A’s return on equity (ROE) stands at -0.07.

Dividend Per Share (DPS):

Bioventus Inc - Class A declared 0 dividend per share during the earnings announcement for Q1 2022.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2022-05-11
0.05
0.04
-20%

Company Information

Bioventus delivers clinically proven, cost-effective products that help people heal quickly and safely. Its mission is to make a difference by helping patients resume and enjoy active lives. The Innovations For Active Healing from Bioventus include offerings for osteoarthritis, surgical and non-surgical bone healing. Built on a commitment to high quality standards, evidence-based medicine and strong ethical behavior, Bioventus is a trusted partner for physicians worldwide.

Organisation
Bioventus Inc - Class A
Employees
700